Search

everythinglearnresearchcommunity

for

Search:↓

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Innate lymphoid cells help us understand and manage allergic diseases better.

Prolactin levels and gene polymorphism are not linked to vitiligo severity but are related to BMI.

The meeting discussed vitamin D3's role in fighting tuberculosis, potential treatments for skin conditions like psoriasis, and hair follicle regeneration as a possible solution for hair loss.

Melatonin directly affects mouse hair follicles and may influence hair growth.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.

A brain-produced steroid causes increased scratching in mice with a skin condition similar to eczema.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Paeoniflorin protects brain cells by involving a specific protein and neurosteroids.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

New treatments for severe alopecia areata show promise but lack standard approval.

EMT plays a key role in skin fibrosis and offers new therapy targets.

A newborn with ichthyosis was successfully treated using specific neonatal care methods.

Polynucleotide-based treatments effectively reduce aging signs and aid tissue recovery.

Expand access to prevention and address barriers for sex workers in Kostanay.